Tuesday, 02 January 2024 12:17 GMT

Twitter Doesn't Oppose Oct. 17 Trial In Musk Buyout Case


(MENAFN- The Peninsula) Bloomberg

Twitter Inc. snapped back at billionaire Elon Musk over accusations it's being intransigent on setting a specific trial date and isn't agreeing to hand over documents. 
The company, which sued Musk after he halted a planned $44 billion takeover, said it was false for the Tesla Inc. co-founder to claim in his own filing on Tuesday that Twitter was insisting 'without justification” on an Oct. 10 trial start.

'Twitter repeatedly informed Musk it does not object to beginning trial on October 17 if the court has sufficient availability to complete a five-day trial that week, provided only that Musk commit not to seek more than five trial days,” the company said in a a filing Wednesday. 

It also rejects the idea it's refusing to hand over documents. 'Twitter agreed to begin a rolling production of documents if Musk did the same,” the company said. 'Musk is the party holding up productive and disciplined discussions on the scope of discovery by delaying filing an answer.”

Read Also
  • Cedars-Sinai ranked No. 1 hospital in California and No. 2 in US
  • World's biggest Swiss flag unfurled on Alpine cliff
  • Philippine ex-President Fidel Ramos dies

The Delaware judge hearing the case agreed last week to fast-track the trial over the cancelled $54.20-per-share deal, and asked both parties to agree to a specific five-day trial in October. 

The social-media platform -- which Musk uses almost daily -- contends the world's richest man is refusing to agree to an even-handed schedule and lobbed a letter onto the court docket without sharing it with his opponents. 

Musk's discovery proposal 'requires Twitter's immediate compliance with extravagant and onerous one-way discovery demands unrelated to the issues to be tried,” Twitter's lawyers said in the 14-page filing.

The case is Twitter v. Musk, 22-0613, Delaware Chancery Court (Wilmington). 


MENAFN31072022000063011010ID1104622709



Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.

Search